Chrigu Wins Grand Prize at First Ever International Documentar…
GENEVA, Sept. 1 /PRNewswire-AsiaNet/ – Reel Lives: The Cancer Chronicles Film Festival awards prizes to top filmmakers Chrigu from Switzerland has been awarded the Grand Prize in the first ever Reel Lives: Cancer Chronicles Film Festival at a ceremony in Geneva, Switzerland. Runners up prizes were also awarded to The Truth About Cancer (USA) for Best... [Read More...]
Open ICON 2008 at Busan BEXCO Starting from September 4 to 5
BUSAN, Sep. 1 /Xinhua-PRNewswire-AsiaNet/ – The second installment of 2008 International Content Creator’s Conference (ICON2008) continuing from last year will be held at Busan BEXCO. (Photo: http://www.newscom.com/cgi-bin/prnh/20080901/HKM001LOGO-a ) ‘ICON2008′ will be in session for two days starting from September 4 – September 5. It is scheduled to have... [Read More...]
AsiaNet Daily Summary – Press Releases for Monday, Sept 1, 2008
SYDNEY, Sept 1 /AsiaNet/ – NAME CHANGE… HELSINKI: Wartsila Corporation’s subsidiary in Singapore, Total Automation Pte Ltd, has been re-named Wartsila Automation Services Singapore Pte Ltd with effect from Sept 1, 2008. WORLD-CHECK APPOINTS… LONDON: World-Check’s Board of Directors Monday announced the appointment of Daniel Peak to the position of Chief Executive... [Read More...]
American Heart Journals Publishes Results From ERATO Trial Sho…
MONTPELLIER, September 01 /PRNewswire-AsiaNet/ – The ERATO study published today in the American Heart Journal demonstrated, for the first time in patients with permanent atrial fibrillation, that dronedarone (Multaq(R)) significantly reduces mean 24 hour ventricular rate, on top of other rate control agents. The mean heart rate reduction was 11.7 beats per minute (p< 0, 0001) with dronedarone... [Read More...]
World-Check Appoints Daniel Peak as New Chief Executive Officer
LONDON, Sept. 1/ PRNewswire-AsiaNet/ – World-Check’s Board of Directors has today announced the appointment of Daniel Peak to the position of Chief Executive Officer. This appointment marks the culmination of a carefully architected expansion of World-Check’s management team that will lead this market-pioneering company through its continued rapid growth. Established in 2000,... [Read More...]
PVSEC Europe 2008: Germany Solidifies Leading Position in PV E…
BERLIN, September 1 /PRNewswire-AsiaNet/ - Germany’s recently approved "climate package" is its latest step in securing the country’s position as a leading investment location in renewable energies. "The reforms maintain attractive feed-in tariffs and strengthen the legal framework for energy-efficiency investments, therefore adding to Germany’s already inviting... [Read More...]
Yevgeniy Timoshenko Wins Historic APT Macau!
MACAU, Aug 31 /PRNewswire-AsiaNet/ – – The Game of Poker Makes Giant Leap in Asia 20-year-old Yevgeniy Timoshenko, a highly rated player from the United States of Ukrainian descent tonight made history by winning the APT Macau, Asia’s largest guaranteed tournament at the glamourous Galaxy StarWorld. 257 players from over 40 countries lined-up for a GUARANTEED prize pool of... [Read More...]
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Eve…
MUNICH, Aug. 31 /PRNewswire-AsiaNet/ – Sub-group analysis of landmark trial showed prasugrel substantially reduced risk of heart attack and stent thrombosis compared with clopidogrel among ACS patients with diabetes Patients who were diabetic and diagnosed with acute coronary syndromes (ACS) were 40 percent less likely to suffer a heart attack if they were treated with... [Read More...]
First Landmark ARB Trial Against Placebo Shows MICARDIS(R) (Te…
MUNICH, August 31 /PRNewswire-AsiaNet/ – – TRANSCEND(R), Parallel Trial to ONTARGET(R), Confirms Long-Term Protective Benefits and Excellent Tolerability Profile of Telmisartan 80mg(1) on Top of Current Best Standard of Care – For non-US Healthcare Media The results of the TRANSCEND(R)* trial demonstrate that MICARDIS(R) 80mg (telmisartan) reduces the risk of cardiovascular... [Read More...]
With the BEAUTIFUL Results, Procoralan* (ivabradine) is the Fi…
MUNICH, Aug 31 /PRNewswire-AsiaNet/ – Press conference The BEAUTIFUL study: a step further in title Coronary Artery Disease ESC Hotline Title: The BEAUTIFUL study: efficacy of session title ivabradine in reduction of cardiovascular events among patients with stable coronary artery disease... [Read More...]
